PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-58.24%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
250.00%
EBIT growth above 1.5x ADI's 121.74%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
250.00%
Operating income growth above 1.5x ADI's 121.74%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
147.06%
Net income growth above 1.5x ADI's 62.96%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
148.23%
EPS growth above 1.5x ADI's 64.29%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
148.23%
Diluted EPS growth above 1.5x ADI's 63.16%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-29.30%
Share reduction while ADI is at 2.66%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-29.30%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
53.23%
Dividend growth of 53.23% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-97.71%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-130.90%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
85.05%
10Y revenue/share CAGR above 1.5x ADI's 49.71%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
69.30%
5Y revenue/share CAGR 1.25-1.5x ADI's 50.70%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
41.60%
3Y revenue/share CAGR above 1.5x ADI's 11.51%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
484.92%
10Y net income/share CAGR of 484.92% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-31.93%
Negative 5Y net income/share CAGR while ADI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-36.89%
Negative 3Y CAGR while ADI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
158.20%
Dividend/share CAGR of 158.20% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
139.08%
3Y dividend/share CAGR of 139.08% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.22%
AR growth is negative/stable vs. ADI's 1.68%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
1.84%
Inventory growth well above ADI's 3.50%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-6.19%
Negative asset growth while ADI invests at 1.31%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
37.76%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
-11.77%
We’re deleveraging while ADI stands at 40.85%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-9.17%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.